A
RLAY icon

AlphaQuest’s Relay Therapeutics RLAY Stock Holding History

AlphaQuest’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,447
Closed -$334K – 1643
2025
Q4 		$334K Buy
+39,447
New +$281K 0.02% 1135
2024
Q4 		– Sell
-1,770
Closed -$12.5K – 1963
2024
Q3 		$12.5K Buy
+1,770
New +$13.2K ﹤0.01% 1538
2024
Q2 		– Sell
-81,295
Closed -$675K – 1837
2024
Q1 		$675K Buy
81,295
+67,915
+508% +$663K 0.12% 293
2023
Q4 		$147K Buy
+13,380
New +$113K 0.03% 693

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

AlphaQuest's RLAY Position: Q1 2026 in Review

AlphaQuest sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 39,447 shares — an estimated $334K sold.

AlphaQuest first reported a position in RLAY in Q4 2023 and held it in 4 quarters. The position peaked at $675K in Q1 2024. 244 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • AlphaQuest reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 39,447 Relay Therapeutics shares in Q1 2026, an estimated $334K.
  • AlphaQuest first reported a position in Relay Therapeutics in Q4 2023 and held it in 4 quarters.
  • AlphaQuest's Relay Therapeutics position peaked at $675K in Q1 2024.
  • 244 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.